NIHON CHOUZAI Co.,Ltd.
NIHON CHOUZAI Co., Ltd., headquartered in Japan, is a leading player in the pharmaceutical industry, specialising in the provision of comprehensive healthcare solutions. Founded in 2000, the company has established a strong presence across various regions in Japan, focusing on the development and distribution of prescription medications and healthcare services. With a commitment to innovation, NIHON CHOUZAI offers unique products that cater to the evolving needs of patients and healthcare providers. Their core services include pharmacy operations, drug dispensing, and health management, all designed to enhance patient care and streamline healthcare delivery. Recognised for its market leadership, NIHON CHOUZAI has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The company's dedication to quality and service excellence continues to drive its success in the competitive pharmaceutical landscape.
DitchCarbon Score
How does NIHON CHOUZAI Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NIHON CHOUZAI Co.,Ltd.'s score of 24 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NIHON CHOUZAI Co.,Ltd.'s reported carbon emissions
In 2022, NIHON CHOUZAI Co., Ltd. reported total carbon emissions of approximately 31,612,000 kg CO2e from Scope 2 and about 5,454,000 kg CO2e from Scope 1, alongside significant Scope 3 emissions of approximately 696,222,800 kg CO2e. The Scope 3 emissions breakdown includes substantial contributions from purchased goods and services (about 611,519,800 kg CO2e) and employee commuting (approximately 3,737,400 kg CO2e). In 2021, the company achieved a reduction in Scope 1 emissions to about 5,766,000 kg CO2e and Scope 2 emissions to approximately 35,205,000 kg CO2e, while also reporting Scope 3 emissions of around 556,700 kg CO2e. This indicates a commitment to reducing their carbon footprint over the years. Despite these figures, NIHON CHOUZAI has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of formal reduction targets suggests a need for further commitment to climate action within the pharmaceutical industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 6,011,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 32,782,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NIHON CHOUZAI Co.,Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
